
Alzamend Neuro, Inc. Common Stock Share Price
NASDAQ: ALZNHealthcare
Live Alzamend Neuro, Inc. Common Stock Share Price Chart
O H L
Alzamend Neuro, Inc. Common Stock Performance Overview
Days Range
▼
$1.83Low
$1.84High
Markets Today
| Previous Close | $1.84 |
|---|---|
| Open | $1.84 |
| Volume | 42,653 |
| Day's Range | $1.83 - $1.84 |
| 52W Range | $0.84 - $2.68 |
| Market Cap | $8.83 M |
Historical Performance
| 1M Returns | +21.05 |
|---|---|
| 3M Returns | +50.82 |
| 6M Returns | -4.17 |
| 1Y Returns | -26.10 |
| 5Y Returns | -99.95 |
| 10Y Returns | NA |
Alzamend Neuro, Inc. Common Stock Fundamentals
| Market Cap | $8.83 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -3.73 |
| EPS TTM | $-2.27 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 10.62 |
| EBITDA | $-8.66 M |
| Profit Margin | N/A |
| Market Cap | $8.83 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -3.73 |
| EPS TTM | $-2.27 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 10.62 |
| EBITDA | $-8.66 M |
| Profit Margin | N/A |
Alzamend Neuro, Inc. Common Stock Profit & Loss
Quarterly
| Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$1.14 M | -$2.70 M | -$998.11 K | -$2.20 M | -$2.87 M | -$3.03 M |
| EBITDA | -$1.13 M | -$2.67 M | -$970.42 K | -$2.17 M | -$2.84 M | -$3.00 M |
| Interest Expense | -$509 | -$2.48 K | -$2.65 K | -$1.34 K | -$150 | -$2.00 K |
| Depreciation | $12.69 K | $27.68 K | $27.68 K | $27.68 K | $27.68 K | $27.68 K |
| Income Before Tax | -$1.14 M | -$2.70 M | -$1.00 M | -$2.20 M | -$2.87 M | -$3.03 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$1.14 M | -$2.70 M | -$1.00 M | -$2.20 M | -$2.87 M | -$3.03 M |
| Net Profit Margin | - | - | - | - | - | - |
Alzamend Neuro, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $78 | $314 | $380 | $380 | $425 | $482 |
| Reserve & Surplus | -$58.54 M | -$61.24 M | -$62.24 M | -$64.44 M | -$67.31 M | -$70.33 M |
| Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Liabilities | $634.76 K | $983.31 K | $717.49 K | $1.86 M | $1.35 M | $2.74 M |
| Total Liabilities | $634.76 K | $983.31 K | $717.49 K | $1.86 M | $1.35 M | $2.74 M |
| Fixed Assets | $425.61 K | $397.92 K | $370.24 K | $342.55 K | $314.87 K | $287.18 K |
| Current Assets | $4.18 M | $5.93 M | $4.72 M | $3.70 M | $1.76 M | $8.25 M |
| Total Assets | $4.60 M | $6.33 M | $5.09 M | $4.04 M | $2.08 M | $8.54 M |
Alzamend Neuro, Inc. Common Stock Cash Flow
Quarterly
| Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$1.14 M | -$2.70 M | -$1.00 M | -$2.20 M | -$2.87 M | -$3.03 M |
| Operating Cash Flow | -$688.71 K | -$2.36 M | -$1.17 M | -$1.74 M | -$2.80 M | -$1.14 M |
| Investing Cash Flow | -$210.00 K | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $1.49 M | $4.04 M | $0 | $0 | $794.84 K | $8.02 M |
| Change in Cash | $590.52 K | $1.67 M | -$1.17 M | -$1.74 M | -$2.00 M | $6.88 M |
Alzamend Neuro, Inc. Common Stock Return Calculator
The Alzamend Neuro, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$5
Invested Amount$10,000
Est. Returns$-9,995
About Alzamend Neuro, Inc. Common Stock
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.
Popular Stocks
FAQs
What is the share price of Alzamend Neuro, Inc. Common Stock today?
Alzamend Neuro, Inc. Common Stock (ALZN) share price as of September 18, 2026 is $1.80. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Alzamend Neuro, Inc. Common Stock?
Yes, Indian Investors can invest in the Alzamend Neuro, Inc. Common Stock (ALZN) Share by opening an international trading account with Angel One.
How can I purchase Alzamend Neuro, Inc. Common Stock shares in India?
Purchasing Alzamend Neuro, Inc. Common Stock (ALZN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Alzamend Neuro, Inc. Common Stock (ALZN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Alzamend Neuro, Inc. Common Stock?
Yes, you can purchase fractional shares of Alzamend Neuro, Inc. Common Stock (ALZN) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Alzamend Neuro, Inc. Common Stock?
The market capitalization of Alzamend Neuro, Inc. Common Stock on September 18, 2026, is $8.83 M.
In which sector Alzamend Neuro, Inc. Common Stock belongs?
Alzamend Neuro, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Alzamend Neuro, Inc. Common Stock stocks?
In order to invest in Alzamend Neuro, Inc. Common Stock (ALZN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
